IDEXX Laboratories Inc (IDXX)
489.24
-5.02
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
489.28
+0.04
(+0.01%)
After-Hours: 20:00
IDEXX Laboratories Cash from Operations (Quarterly): 249.85M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 249.85M |
September 30, 2023 | 272.43M |
June 30, 2023 | 200.31M |
March 31, 2023 | 183.91M |
December 31, 2022 | 173.43M |
September 30, 2022 | 189.00M |
June 30, 2022 | 65.85M |
March 31, 2022 | 114.71M |
December 31, 2021 | 209.96M |
September 30, 2021 | 187.20M |
June 30, 2021 | 233.96M |
March 31, 2021 | 124.42M |
December 31, 2020 | 218.93M |
September 30, 2020 | 193.12M |
June 30, 2020 | 208.14M |
March 31, 2020 | 27.87M |
December 31, 2019 | 155.41M |
September 30, 2019 | 132.26M |
June 30, 2019 | 137.10M |
March 31, 2019 | 34.38M |
December 31, 2018 | 135.65M |
September 30, 2018 | 110.71M |
June 30, 2018 | 118.83M |
March 31, 2018 | 34.90M |
December 31, 2017 | 121.13M |
Date | Value |
---|---|
September 30, 2017 | 110.68M |
June 30, 2017 | 110.19M |
March 31, 2017 | 31.27M |
December 31, 2016 | 100.76M |
September 30, 2016 | 100.32M |
June 30, 2016 | 110.88M |
March 31, 2016 | 26.99M |
December 31, 2015 | 79.33M |
September 30, 2015 | 76.95M |
June 30, 2015 | 80.17M |
March 31, 2015 | -14.64M |
December 31, 2014 | 27.30M |
September 30, 2014 | 93.26M |
June 30, 2014 | 81.76M |
March 31, 2014 | 33.52M |
December 31, 2013 | 65.42M |
September 30, 2013 | 78.10M |
June 30, 2013 | 81.43M |
March 31, 2013 | 21.06M |
December 31, 2012 | 68.92M |
September 30, 2012 | 74.69M |
June 30, 2012 | 63.62M |
March 31, 2012 | 15.18M |
December 31, 2011 | 54.40M |
September 30, 2011 | 75.21M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
27.87M
Minimum
Mar 2020
272.43M
Maximum
Sep 2023
172.52M
Average
187.20M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
Stryker Corp | 1.528B |
Haemonetics Corp | -0.54M |
Align Technology Inc | 46.90M |
Edwards Lifesciences Corp | 136.60M |
ACADIA Pharmaceuticals Inc | 85.39M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -30.44M |
Cash from Financing (Quarterly) | -101.84M |
Free Cash Flow | 772.88M |
Free Cash Flow Per Share (Quarterly) | 2.589 |
Free Cash Flow to Equity (Quarterly) | 288.22M |
Free Cash Flow to Firm (Quarterly) | 221.87M |
Free Cash Flow Yield | 1.88% |